ZYUS Life Sciences Corporation
ZYUS.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.63M | -3.20M | -2.76M | -15.53M | -2.87M |
| Total Depreciation and Amortization | 524.90K | 488.60K | 483.60K | 565.80K | 528.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 310.70K | 451.00K | 374.20K | 13.28M | 203.10K |
| Change in Net Operating Assets | -34.90K | 847.80K | -71.80K | -2.10M | 1.04M |
| Cash from Operations | -1.83M | -1.41M | -1.97M | -3.79M | -1.10M |
| Capital Expenditure | -6.50K | -- | -- | -700.00 | -8.10K |
| Sale of Property, Plant, and Equipment | 0.00 | 18.10K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 1.34M | 0.00 |
| Cash from Investing | -6.50K | 18.10K | -- | 1.34M | -8.10K |
| Total Debt Issued | 2.38M | 1.91M | 1.75M | 5.00M | 300.00K |
| Total Debt Repaid | -50.00K | -89.00K | -158.00K | -17.00K | -2.60M |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 3.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.69M | 1.32M | 1.11M | 3.56M | 744.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.80K | -75.20K | -863.30K | 1.11M | -359.30K |